It’s All Happening… Thanks to You! HATCH Breaks Ground After 18 months of planning, designing, networking and studying the needs of the Bioscience industry, HATCH has started construction… We have been honored to meet and collaborate with brilliant and dedicated stakeholders that make up the Bioscience ecosystem in the Greater Los Angeles area and have … Continue reading HATCH Breaks Ground in the LA BioScience HUB
CLSI is offering a new professional development seminar on February 28 aimed at helping participants understand the complex decisions that guide drug pricing decisions. Taught by Biotech Primer, “Understanding Drug Pricing” will provide invaluable information to those in government, finance, law, insurance and human resources who are seeking to gain a better grasp on how … Continue reading NEW COURSE on UNDERSTANDING DRUG PRICING
Professor Jeremy Sanford launches new approach to increase undergraduate research experience Molecular Biologist Jeremy Sanford wants to expand opportunities for students to engage in meaningful, hands-on research projects at UC Santa Cruz. To overcome the limited number of student-researcher positions, Sanford is bringing his research into the laboratory classroom, where undergraduates can contribute. Sanford’s Curricular … Continue reading Guest Article: UC Santa Cruz MCD Biology launches Curricular Undergraduate Research Experiences (CUREs) Initiative
FAST & Fellows Round-Up Inflammatix (FAST Fall 2017), a molecular diagnostics company that is developing rapid tests that read the immune system to improve disease diagnosis, announces appointment of Oliver Liesenfeld, M.D., former CMO of Roche Molecular Diagnostics, as Chief Medical Officer Read More LogicInk (FAST Spring 2017) is planning on launching its … Continue reading FAST, Fellow and CARB-X Updates January 2018
By: Sara Radcliffe CLSA President & CEO December 21, 2017 The California Life Sciences Association (CLSA), along with the California Life Sciences Institute (CLSI), would like to thank everyone – members, board members, national organization partners, strategic partners, academic partners and the California life sciences community – for your membership, support and participation throughout the … Continue reading President’s Corner – 2017 Year in Review
On Dec. 20, Congress passed a sweeping overhaul of the tax code in the form of H.R. 1, the Tax Cuts and Jobs Act. While CLSA did not take a position on the overall legislation, we did work in close collaboration and coordination with BIO and our CLSA member companies to ensure that the Orphan Drug Tax Credit – a meaningful incentive for investment in rare disease therapy innovation – was preserved in the final bill passed by Congress.
This month, Reps. Erik Paulsen (R-Minn.) and Jackie Walorski (R-Ind.) and House Ways & Means Committee Chairman Brady (R-Texas) introduced new legislation to provide a 5-year suspension of the medical device excise tax (H.R. 4617). The current suspension of the 2.3% medical device excise tax expires Dec. 31, 2017.
By Erin Righetti Your free copy of the J.P. Morgan Conference 2018 Survival Guide The teeming influx of life science industry folk in San Francisco during the second week of January represents the zenith of the 36th annual J.P. Morgan Healthcare Conference pilgrimage. Concurrent events add to the draw for the who’s who of life science … Continue reading Your Free Guide to Surviving JPM San Francisco 2018
November 07, 2017 By Jen Ralls 10,000 Fitbit devices to be used for research in national program SAN FRANCISCO–(BUSINESS WIRE)– Fitbit (NYSE:FIT), the leading global wearables brand, announced today it has been selected as the first wearable for use in the national All of Us Research Program established by the White House in 2015. This project is funded by a supplement to a funding award … Continue reading Fitbit Selected for National Institutes of Health (NIH) Precision Medicine Research Program with The Scripps Research Institute (TSRI)
December 1, 2017 By Paola Bonilla The option that patients have right now about participating in research or a pilot program sending health Information remotely to HealthCare Institutions, Providers, Payers and Pharma has shown tremendous benefits in improving patient treatments, including medication. But the more remotely devices usability to send health or medical data, the more … Continue reading Security Of Patient Data During Research and Pilots Programs